Substrate specificity of heparanases from human hepatoma and platelets

被引:217
作者
Pikas, DS
Li, JP
Vlodavsky, I
Lindahl, U
机构
[1] Univ Uppsala, Dept Med Biochem & Microbiol, Ctr Biomed, S-75123 Uppsala, Sweden
[2] Hadassah Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel
关键词
D O I
10.1074/jbc.273.30.18770
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparan sulfate proteoglycans, attached to cell surfaces or in the extracellular matrix, interact with a multitude of proteins via their heparan sulfate side chains. Degradation of these chains by limited (endoglycosidic) heparanase cleavage is believed 60 affect a variety of biological processes. Although the occurrence of heparanase activity in mammalian tissues has been recognized for many years, the molecular characteristics and substrate recognition properties of the enzyme(s) have remained elusive. In the present study, the substrate specificity and cleavage site of heparanase from human hepatoma and platelets were investigated. Both enzyme preparations were found to cleave the single beta-D-glucuronidic Linkage of a heparin octasaccharide. A capsular polysaccharide from Escherichia coli K5, with the same (-GlcUA beta 1, 4-GlcNAc alpha 1,4-)(n) structure as the unmodified backbone of heparan sulfate, resisted heparanase degradation in its native state as well as after chemical N-deaeetylation/N-sulfation or partial enzymatic C-5 epimerization of beta-DGlcUA to alpha-L-IdceA By contrast, a chemically O-sulfated (but still N-acetylated) K5 derivative was susceptible to heparanase cleavage. O-Sulfate groups, but not N-sulfate or IdceA residues, thus are essential for substrate recognition by the heparanase(s). In particular, selective O-desulfation of the heparin octasaccharide implicated a 2-O-sulfate group on a hexuronic acid residue located two monosaccharide units from the cleavage site, toward the reducing end.
引用
收藏
页码:18770 / 18777
页数:8
相关论文
共 51 条
[1]   Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids [J].
Bai, XM ;
Bame, KJ ;
Habuchi, H ;
Kimata, K ;
Esko, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23172-23179
[2]  
Bame KJ, 1997, J BIOL CHEM, V272, P2245
[3]  
BAME KJ, 1993, J BIOL CHEM, V268, P19956
[4]   BASIC FIBROBLAST GROWTH-FACTOR BINDS TO SUBENDOTHELIAL EXTRACELLULAR-MATRIX AND IS RELEASED BY HEPARITINASE AND HEPARIN-LIKE MOLECULES [J].
BASHKIN, P ;
DOCTROW, S ;
KLAGSBRUN, M ;
SVAHN, CM ;
FOLKMAN, J ;
VLODAVSKY, I .
BIOCHEMISTRY, 1989, 28 (04) :1737-1743
[5]  
CAMPBELL P, 1994, J BIOL CHEM, V269, P26953
[6]   HEPARIN-LIKE COMPOUNDS PREPARED BY CHEMICAL MODIFICATION OF CAPSULAR POLYSACCHARIDE FROM ESCHERICHIA-COLI K5 [J].
CASU, B ;
GRAZIOLI, G ;
RAZI, N ;
GUERRINI, M ;
NAGGI, A ;
TORRI, G ;
ORESTE, P ;
TURSI, F ;
ZOPPETTI, G ;
LINDAHL, U .
CARBOHYDRATE RESEARCH, 1994, 263 (02) :271-284
[7]   INTEGRAL MEMBRANE HEPARAN-SULFATE PROTEOGLYCANS [J].
DAVID, G .
FASEB JOURNAL, 1993, 7 (11) :1023-1030
[8]   Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain [J].
Feyzi, E ;
Lustig, F ;
Fager, G ;
Spillmann, D ;
Lindahl, U ;
Salmivirta, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5518-5524
[9]   Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts [J].
Goshen, Ran ;
Hochberg, Abraham A. ;
Korner, Gil ;
Levy, Ehud ;
Ishai-Michaeli, Rivka ;
Elkin, Michael ;
de Groot, Nathan ;
Vlodaysky, Israel .
MOLECULAR HUMAN REPRODUCTION, 1996, 2 (09) :679-684
[10]  
Graham LD, 1996, BIOCHEM MOL BIOL INT, V39, P563